Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results , but sales fell by 10.3% year on year to $165 million.

Single cell sequencing can address tissue specific and/or cell type specific biological questions by examining RNA expression or epigenetic information on the single cell level. The Genomics Core ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Coupled with the invalidation of 10x Genomics’ 10,155,981 patent ... a fundamentally differentiated solution that makes single cell sequencing more scalable without the need for expensive ...

This collaboration will use 10x Genomics' Chromium GEM-X technology for single-cell ... like the Billion Cells Project showcase advances enabled by our innovative sequencing architecture combined ...

Landmark single ... billion cell dataset to fuel rapid progress in AI model development in biology. CZI is embarking on this landmark initiative in collaboration with partners 10x Genomics ...